Models and strategies in the development of antiobesity drugs

Vet Pathol. 2014 May;51(3):695-706. doi: 10.1177/0300985813492801. Epub 2013 Jul 16.

Abstract

Obesity is a leading cause of morbidity and mortality worldwide. There is still a wide disparity between the necessity and availability of safe and effective antiobesity pharmacotherapies. Current drugs are associated with adverse effects and are limited in their efficacy. There is thus an urgent need for new antiobesity agents. Animal models are critical to the study of the biological mechanisms underpinning energy homeostasis and obesity and provide useful tools for the development of novel antiobesity agents. Our understanding of the complex neuronal and hormonal systems that regulate appetite and body weight has largely been based on studies in animals. This review describes the physiological basis of appetite, rodent models used in the development of antiobesity drugs, and potential future targets for novel antiobesity agents.

Keywords: animal; antiobesity drugs; appetite; models; obesity.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Obesity Agents / adverse effects
  • Anti-Obesity Agents / chemical synthesis*
  • Anti-Obesity Agents / pharmacology*
  • Appetite / drug effects
  • Appetite / physiology*
  • Cats
  • Disease Models, Animal*
  • Drug Discovery / methods*
  • Ghrelin / pharmacology
  • Humans
  • Mice
  • Obesity / drug therapy*
  • Oxyntomodulin / pharmacology
  • Primates
  • Rats
  • Swine

Substances

  • Anti-Obesity Agents
  • Ghrelin
  • Oxyntomodulin